Ain Shams University: Non-alcoholic Fatty Liver Disease trials

The registry lists 12 Non-alcoholic Fatty Liver Disease studies with Ain Shams University as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 3Phase 4 3No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Not yet recruitingNCT07310407Phase 2
• Hepatoprotective Measures for Children at High Risk of NAFLDActive, not recruitingNCT06918080Phase 4
• Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 DiabetesCompletedNCT06348706Phase 3
• Probiotic Supplementation IN NAFLD PatientsCompletedNCT06074094Phase 4
• Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease PatientsStatus unknownNCT05613192Phase 3
• N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver DiseaseCompletedNCT05589584Phase 3
• Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD PatientsCompletedNCT05474560Phase 4
• Impact Of Choline in Patients With NAFLDStatus unknownNCT05200156Not applicable
• Omega 3 Supplementation in Children With Non Alcoholic Fatty LiverCompletedNCT04281121Not applicable
• Nicotinamide in Non-Alcoholic Fatty Liver Disease PatientsCompletedNCT03850886Phase 2
• Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C VirusCompletedNCT03276039
• Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD PatientsCompletedNCT03250572